Edap Tms (NASDAQ:EDAP) Stock Passes Above 200 Day Moving Average – Time to Sell?

Edap Tms S.A. (NASDAQ:EDAP) crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $1.91 and traded as high as $2.24. Edap Tms shares last traded at $1.99, with a volume of 65,938 shares changing hands.

Analyst Ratings Changes

A number of equities analysts have weighed in on the stock. Jefferies Financial Group reiterated a “hold” rating and set a $2.00 target price on shares of Edap Tms in a research report on Thursday. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Edap Tms in a report on Wednesday, October 8th. One analyst has rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock has an average rating of “Hold” and an average price target of $8.50.

Edap Tms Stock Performance

The stock has a market capitalization of $74.41 million, a P/E ratio of -3.26 and a beta of -0.18. The company has a quick ratio of 1.05, a current ratio of 1.51 and a debt-to-equity ratio of 0.04. The company has a 50-day moving average price of $2.35 and a two-hundred day moving average price of $1.91.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the company. Simplicity Wealth LLC bought a new position in shares of Edap Tms in the second quarter worth $54,000. Cetera Investment Advisers increased its holdings in shares of Edap Tms by 33.9% in the 1st quarter. Cetera Investment Advisers now owns 75,000 shares of the medical equipment provider’s stock worth $147,000 after buying an additional 19,000 shares during the last quarter. Sage Mountain Advisors LLC purchased a new stake in Edap Tms during the second quarter valued at about $165,000. Scoggin Management LP bought a new stake in Edap Tms during the first quarter worth about $686,000. Finally, Banque Transatlantique SA increased its position in shares of Edap Tms by 7,063.7% during the 1st quarter. Banque Transatlantique SA now owns 730,699 shares of the medical equipment provider’s stock valued at $1,324,000 after purchasing an additional 720,499 shares during the last quarter. 62.74% of the stock is currently owned by hedge funds and other institutional investors.

Edap Tms Company Profile

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.